Continuous Intercostal Nerve Block for Multiple Rib Fractures
This study is looking at how well a continuous intercostal nerve block (CINB) with Ropivacaine helps patients with multiple broken ribs. You could be eligible if you are at least 18 years old and have two or more broken ribs. The study compares CINB plus standard pain medicine (non-steroidal anti-inflammatory drugs and opioids) to standard pain medicine alone. Researchers want to see if CINB can reduce how long patients need to stay in the hospital. The study is currently recruiting 180 participants, but its overall status is unclear.
- Study design
- This is a prospective, randomized study comparing two treatment groups. It is not blinded, meaning both you and your doctors will know which treatment you are receiving. The study plans to enroll 180 participants.
- What's involved
- Patients in the CINB group will have a catheter placed to deliver Ropivacaine. Patients in the other group will receive standard pain medications. The study measures your length of hospital stay.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary outcome, length of hospital stay, is measured at 7 days.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
INTERCOSTAL NERVE BLOCK: Efficacy of CINB for Patients With Multiple Rib Fractures
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Zachary Warriner, MD · PRINCIPAL_INVESTIGATOR · University of Kentucky
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Length of hospital stay7 days
time from randomization until the time of discharge